Literature DB >> 26865201

Renal Resistive Index Predicts Postoperative Blood Pressure Outcome in Primary Aldosteronism.

Yoshitsugu Iwakura1, Sadayoshi Ito1, Ryo Morimoto1, Masataka Kudo1, Yoshikiyo Ono1, Masahiro Nezu1, Kei Takase1, Kazumasa Seiji1, Shigeto Ishidoya1, Yoichi Arai1, Yasuharu Funamizu1, Takashi Miki1, Yasuhiro Nakamura1, Hironobu Sasano1, Fumitoshi Satoh2.   

Abstract

The renal resistive index (RI) calculated by Doppler ultrasonography has been reported to be correlated with renal structural changes and outcomes in patients with essential hypertension or renal disease. However, little is known about this index in primary aldosteronism. In this prospective study, we examined the utility of this index to predict blood pressure (BP) outcome after adrenalectomy in patients with primary aldosteronism. We studied 94 patients with histopathologically proven aldosteronoma who underwent surgery. Parameters on renal function, including renal flow indices, were examined and followed up for 12 months postoperatively. The renal RI of the main, hilum, and interlobar arteries was significantly higher in patients with aldosteronoma compared with 100 control patients. BP, estimated glomerular filtration rate, and urinary albumin excretion significantly decreased after adrenalectomy. The resistive indices of all compartment arteries were significantly reduced 1 month after adrenalectomy and remained stable for 12 months. Patients whose interlobar RI was in the highest tertile at baseline had higher systolic BP after adrenalectomy than those whose RI was in the lowest tertile. Logistic regression analysis demonstrated that the RI of the interlobar and hilum arteries could be an independent predictive marker for intractable hypertension (systolic BP ≥140 mm Hg, increased BP, taking ≥3 antihypertensive agents, or increased number of agents) even after adrenalectomy. Therefore, in patients with aldosteronoma, the renal RI indicates partially reversible renal hemodynamics and renal structural damages that would influence postoperative BP outcome.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  adrenalectomy; blood pressure; hyperaldosteronism; hypertension; ultrasonography, Doppler

Mesh:

Year:  2016        PMID: 26865201     DOI: 10.1161/HYPERTENSIONAHA.115.05924

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.

Authors:  Ryo Morimoto; Yoshikiyo Ono; Yuta Tezuka; Masataka Kudo; Sachiko Yamamoto; Toshiaki Arai; Celso E Gomez-Sanchez; Hironobu Sasano; Sadayoshi Ito; Fumitoshi Satoh
Journal:  Hypertension       Date:  2017-06-26       Impact factor: 10.190

2.  Aldosterone-producing adenoma associated with non-suppressed renin: a case series.

Authors:  Pieter Martijn Jansen; Michael Stowasser
Journal:  J Hum Hypertens       Date:  2021-03-30       Impact factor: 3.012

Review 3.  Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.

Authors:  Robert M Carey
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

Review 4.  Progress in the Management of Primary Aldosteronism.

Authors:  Ryo Morimoto; Kei Omata; Sadayoshi Ito; Fumitoshi Satoh
Journal:  Am J Hypertens       Date:  2018-04-13       Impact factor: 2.689

5.  Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease.

Authors:  Haiyang Li; Yunzhu Shen; Zhikai Yu; Yinghui Huang; Ting He; Tangli Xiao; Yan Li; Jiachuan Xiong; Jinghong Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-14       Impact factor: 5.555

Review 6.  Renal resistive index in hypertensive patients.

Authors:  Ioannis Andrikou; Costas Tsioufis; Dimitris Konstantinidis; Alexandros Kasiakogias; Kyriakos Dimitriadis; Ioannis Leontsinis; Eirini Andrikou; Elias Sanidas; Ioannis Kallikazaros; Dimitris Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-25       Impact factor: 3.738

7.  Renal Injuries in Primary Aldosteronism: Quantitative Histopathological Analysis of 19 Patients With Primary Adosteronism.

Authors:  Hiroko Ogata; Yuto Yamazaki; Yuta Tezuka; Xin Gao; Kei Omata; Yoshikiyo Ono; Yoshihide Kawasaki; Tomoaki Tanaka; Hidekazu Nagano; Norio Wada; Yutaka Oki; Akira Ikeya; Kenji Oki; Yoshiyu Takeda; Mitsuhiro Kometani; Kazunori Kageyama; Ken Terui; Celso E Gomez-Sanchez; Shujun Liu; Ryo Morimoto; Kensuke Joh; Hiroshi Sato; Mariko Miyazaki; Akihiro Ito; Yoichi Arai; Yasuhiro Nakamura; Sadayoshi Ito; Fumitoshi Satoh; Hironobu Sasano
Journal:  Hypertension       Date:  2021-06-14       Impact factor: 9.897

8.  Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.

Authors:  Silvia Lai; Luigi Petramala; Daniela Mastroluca; Emanuela Petraglia; Alessandro Di Gaeta; Elena Indino; Valeria Panebianco; Mauro Ciccariello; Hossein H Shahabadi; Alessandro Galani; Claudio Letizia; Anna Rita D'Angelo
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

9.  A Clinical Association between an Increasing Renal Resistive Index and the Atherosclerotic Burden in Patients with a Preserved Renal Function.

Authors:  Ippei Watanabe; Yodo Shintani; Shigenori Terada; Takahiro Fujii; Shunsuke Kiuchi; Rine Nakanishi; Tomoyuki Katayanagi; Muneyasu Kawasaki; Keiichi Tokuhiro; Hidefumi Ohsawa; Takanori Ikeda
Journal:  Intern Med       Date:  2020-04-01       Impact factor: 1.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.